isabelobrien, Author at European Medical Journal - Page 6 of 68

Doctor using a laptop

Pharma's role in building next-gen patient case studies

As HCPs seek richer learning experiences, interactive patient case studies are bridging the gap.

Theramex's CEO Robert Stewart on men's role in women's health

Theramex’s CEO discusses the role men must play in improving women’s health, the importance of breaking taboos and why funding is key.

A spray of red and blue stars

FDA moves to accelerate biosimilar approvals

FDA will undertake steps to accelerate the process of developing biosimilars, while also reducing development costs.

Month in pharma news, explained

Month in pharma news, explained – October 2025

Read this month’s pharma news roundup, featuring brain-computer interfaces, a new world record and a cost-effectiveness conundrum.

Big ben and book with british flag

New VPAG deadline extension announced by ABPI

The UK government has extended the deadline for organisations to submit notice to leave the scheme by two weeks.

Coins on blue background

Novartis bets $12bn on RNA with Avidity buy

Novartis to acquire Avidity Biosciences for $12bn, boosting its RNA neuromuscular pipeline as pharma M&A heats up in the RNA space.

Pieter Sonneveld

Hema Now: Episode 28: Charting a New Era in Myeloma Care

What breakthroughs are redefining multiple myeloma treatment and patient outcomes?

Quantam symbol

Google quantum chip could speed up drug discovery

Google’s Quantum Echoes breakthrough could revolutionise drug discovery, offering faster, more precise ways to design new medicines.

Can the UK reclaim its status as a life sciences leader?

Two UK health leaders reveal how to boost life sciences R&D, attract investment and make the UK a global hub once more.

Cell-based flu vaccines could offer 20% more protection

CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.